New From Virbac - Inflacam® A Meloxicam-based NSAID

Virbac has introduced Inflacam®, a meloxicam-based NSAID indicated for the alleviation of pain in both acute and chronic musculo-skeletal disorders in dogs and horses. Inflacam is presented both as an oral suspension and as a chewable tablet for dogs. The suspension is available in 200ml, 100ml, 42ml and 15ml sizes with a measuring syringe provided. The tablets come in two sizes – 1 mg and 2.5 mg – and are available in packs of 100. It is available for horses as an oral suspension. Virbac Product Manager Chris Geddes MRCVS, comments: “Virbac is well known for launching innovative products in areas such as dermatology and reproduction but we also aim to support practices by offering tried and trusted practice ‘standards’ for everyday use. Inflacam fits this brief well – meloxicam is the most commonly-used NSAID in dogs and we are delighted to add it to our range.” For more information vets are advised to contact their territory manager or call Virbac on 01359 243 243.

More from

• Vetsure Named Business of the Year at 2025 SME National Business Awards
• Home of hope for Romania's dogs: The pioneering shelter doing things differently
• Pioneering new locum platform transforming veterinary landscape
• Key Stakeholders unite to advance helmet design for equine veterinary professionals
• Hallmarq hails transformational equine imaging technology